Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company's Ophthalmic Pharmaceutical Business
Durham-based Aerie Pharma is sold to global eye care giant in deal worth $770M - Research Triangle Regional Partnership
Aerie Pharmaceuticals | PPT
Aerie Pharmaceuticals and GrayBug Announce Research Collaboration | Business Wire
Aerie Pharmaceuticals | Capital Sign Solutions
Alcon to Acquire Aerie Pharmaceuticals, Inc., Enhancing its Ophthalmic Pharmaceutical Portfolio
AERIE PHARMACEUTICALS, INC. - Aerie Pharmaceuticals, Inc. Trademark Registration
Rx Item-Rocklatan 0.02% 2.5 ML O/S-Keep Refrigerated - by Ae
Aerie Pharmaceuticals - Crunchbase Company Profile & Funding
AERIE PHARMACEUTICALS, INC. NPS 2022
AeriePharma (@AeriePharma) / X
Rx Item-RHOPRESSA 0.02 % O/S 2.5 ML netarsudil mesylate DROPS BY AERIE PHARMA
Aerie Pharmaceuticals (AERI) Stock | Helping Treatment with Glaucoma - Warrior Trading News
Aerie Pharma Seeks FDA Nod to Sell Ireland-based Product in US | INN
Aerie Pharmaceuticals (AERI) Axitinib Implant (AR-14034) Overview - Slideshow (NASDAQ:AERI) | Seeking Alpha
Alcon ups its glaucoma game again with $770M Aerie Pharma acquisition - MedCity News
Articles about Aerie Pharmaceuticals, Inc.
Aerie Pharmaceuticals | Capital Sign Solutions
Aerie Pharmaceuticals Inc. Company Profile - The Business Journals
Aerie Pharma appoints Richard Rubino as CFO | Healthcare Digital
Aerie Pharma Re-Ups In Irvine, CEO Departs - Orange County Business Journal
Aerie Pharma rockets on news of takeover bid
Aerie Pharma slips after announcing eye disease trial failed to meet primary endpoints | Seeking Alpha
Aerie Pharmaceuticals to Merge with Global Eye-Care Company Alcon | North Carolina Biotechnology Center
Open-angle glaucoma therapeutics market size to grow by USD 2.58 billion from 2021 to 2026; AbbVie Inc. and Aerie Pharmaceuticals Inc, among others, emerge as key vendors - Technavio
Aerie to build manufacturing facility in Ireland
